Febbo Phillip G. insider trades
Febbo Phillip G. has filed 23 Form 4s with the SEC that we hold, for Veracyte, INC. (VCYT) (Chief Scientific & Med Officer) and Illumina, INC. (ILMN) (SVP Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 9 sales worth $2.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($1.0M). The largest single trade was a sale of 1,988 shares of Illumina, INC. worth $715.7K, dated 2022-04-06. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-11-09 and the latest 2026-09-04.
Veracyte, INC. (VCYT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-04 | S, sale reported on Form 4 | 3,934 | $173.5K | 2024-12-06 |
| 2025-03-04 | S, sale reported on Form 4 | 4,467 | $146.8K | 2025-03-06 |
| 2025-03-04 | S, sale reported on Form 4 | 3,570 | $121.2K | 2025-03-06 |
| 2025-10-06 | S, sale reported on Form 4 | 8,349 | $300.7K | 2025-10-07 |
| 2026-03-02 | S, sale reported on Form 4 | 13,425 | $485.4K | 2026-03-04 |
| 2026-09-04 | S, sale reported on Form 4 | 10,405 | $446.3K | 2026-09-04 |
| 2026-09-04 | S, sale reported on Form 4 | 2,705 | $118.1K | 2026-09-04 |
Illumina, INC. (ILMN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-08 | S, sale reported on Form 4 | 1,000 | $406.8K | 2021-11-09 |
| 2022-04-06 | S, sale reported on Form 4 | 1,988 | $715.7K | 2022-04-07 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1649245) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms